Laman UtamaE1WL34 • BVMF
add
Edwards Lifesciences Corp Bdr
Tutup sebelumnya
R$107.14
Julat tahun
R$85.00 - R$129.61
Permodalan pasaran
44.36B USD
Bilangan Purata
45.00
Dalam berita
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
| (USD) | Mac 2025info | Perubahan T/T |
|---|---|---|
Hasil | 1.41B | 4.89% |
Perbelanjaan pengendalian | 701.20J | 1.53% |
Pendapatan bersih | 358.00J | 1.73% |
Margin untung bersih | 25.34 | -3.02% |
Pendapatan bagi setiap syer | 0.64 | -3.03% |
EBITDA | 448.70J | 12.60% |
Kadar cukai berkesan | 16.20% | — |
Kunci Kira-kira
Jumlah aset
Jumlah liabiliti
| (USD) | Mac 2025info | Perubahan T/T |
|---|---|---|
Pelaburan tunai dan jangka pendek | 3.98B | 134.21% |
Jumlah aset | — | — |
Jumlah liabiliti | — | — |
Jumlah ekuiti | 10.06B | — |
Syer tertunggak | 587.90J | — |
Harga kepada buku | 6.31 | — |
Pulangan pada aset | — | — |
Pulangan pada modal | 9.52% | — |
Aliran Tunai
Perubahan bersih dalam tunai
| (USD) | Mac 2025info | Perubahan T/T |
|---|---|---|
Pendapatan bersih | 358.00J | 1.73% |
Tunai daripada operasi | — | — |
Tunai daripada pelaburan | — | — |
Tunai daripada pembiayaan | — | — |
Perubahan bersih dalam tunai | — | — |
Aliran tunai bebas | — | — |
Perihal
Edwards Lifesciences is an American medical technology company headquartered in Irvine, California, specializing in artificial heart valves and hemodynamic monitoring. It developed the SAPIEN transcatheter aortic heart valve made of cow tissue within a balloon-expandable, cobalt-chromium frame, deployed via catheter. The company has manufacturing facilities at the Irvine headquarters, as well as in Draper, Utah; Costa Rica; the Dominican Republic; Puerto Rico; and Singapore; and is building a new facility due to be completed in 2021 in Limerick, Ireland. Wikipedia
Diasaskan
1958
Ibu pejabat
Tapak web
Pekerja
15,800
